Casey C. Case
Plus aucun poste en cours
Profil
Casey C.
Case worked as a Director of Transcription Research at OSI Pharmaceuticals, Inc. from 1989 to 1993.
From 1993 to 1997, he worked as a Director of Cell Biology at Tularik, Inc. He then worked as a Vice President of Research & Operations at Sangamo Therapeutics, Inc. from 1997 to 2005.
After that, he worked as a Chief Scientific Officer at Multispan, Inc. and as a Vice President of Research at SanBio, Inc. from 2006 to 2012.
Dr. Case earned a doctorate degree from the University of California, Davis.
Anciens postes connus de Casey C. Case
| Sociétés | Poste | Fin |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Directeur des opérations | 18/11/2005 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1997 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/1993 |
Multispan, Inc.
 Multispan, Inc. BiotechnologyHealth Technology Multispan, Inc. develops assay tools for G-protein coupled receptor (GPCR) for research applications. It offers GPCR cell line reagents for drug screening assays, compound profiling, and monoclonal antibody generation. The firm also offers GPCR cDNA Bank that provides clones for GPCR expression in mammalian cells; and high expression cell lines, as well as cell line development services. The company was founded by Helena Suyang Mancebo and Jeng-Horng Her in 2004 and is headquartered in Hayward, CA. | Directeur Technique/Scientifique/R&D | - |
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de Casey C. Case
| University of California, Davis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Multispan, Inc.
Multispan, Inc. BiotechnologyHealth Technology Multispan, Inc. develops assay tools for G-protein coupled receptor (GPCR) for research applications. It offers GPCR cell line reagents for drug screening assays, compound profiling, and monoclonal antibody generation. The firm also offers GPCR cDNA Bank that provides clones for GPCR expression in mammalian cells; and high expression cell lines, as well as cell line development services. The company was founded by Helena Suyang Mancebo and Jeng-Horng Her in 2004 and is headquartered in Hayward, CA. | Health Technology |